|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/14 | |||
| A61K 9/48 |
| (11) | Patento numeris | 2925304 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13859441.1 |
| Europos patento paraiškos padavimo data | 2013-11-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/072249 |
| Data | 2013-11-27 |
| (87) | Numeris | WO 2014/085599 |
| Data | 2014-06-05 |
| (30) | Numeris | Data | Šalis |
| 201261731901 P | 2012-11-30 | US |
| (72) |
BRZECZKO, Albert, W., US
HOLLENBECK, R., Gary, US
|
| (73) |
Acura Pharmaceuticals, Inc.,
616 N. North Court, Palatine, IL 60067,
US
|
| (54) | SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT |
| SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT |